Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Neither compound is intended to diagnose, treat, cure, or prevent any disease
Nogo-66 inhibits adhesion and migration of microglia via GTPase rho pathway in vitro
Danuglipron is an investigational medicine that is taken as a tablet by mouth and is currently not approved for use by health authorities
Handling requires biosafety protocols in compliance with laboratory standards Explore our complete catalog of high-purity, third-party tested research compounds by visiting our main Home Page for all your laboratory needs
US$ 22.72
US$ 29.69
US$ 21.06
US$ 29.83
US$ 28.62
